HIV Patients Cohort

Patients Affected by the HIV Clinical Trial

— OVIHD  

Official title:

Constitution of an Open Monocentric Cohort of HIV Infected Patients

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT02203006
• Other study ID #: IDRCB : 2010-A00417-32
• Status: Active, not recruiting
• Phase: N/A
• Start date: October 19, 2011
• Est. completion date: April 2031

Study information

• Verified date: October 2022
• Source: Assistance Publique - Hôpitaux de Paris
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to improve our knowledge concerning HIV infection, treated or not, in the current conditions of care to optimize it.

Description:

Since the arrival of highly active tritherapies, HIV infection became mainly an ambulatory chronic pathology centred on a long term care taking into account the complication of long-term treatment as well as the arisen of new problem bound to a prolonged survival and ageing. So the care is more and more in a prevention and screening approach with in particular the care of metabolic and cardiovascular complication due to antiretroviral treatment.

As a reorganization of the coverage of the HIV infected people take place on the Hotel Dieu Hospital it thus seems important to double this care optimization with a clinical research side. This will be done in constituting an HIV patient cohort including a blood sample collection to contribute to the vigilance of the complication to due the infection.

Our ultimate objective is to optimize the selection of the treatment. It is important to do it to be able to have, on many years duration, precise clinical information and biological sample allowing to realize later some assay and analyse the influence of some genetic markers.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 1613
• Est. completion date: April 2031
• Est. primary completion date: October 2030
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Aged =18 years old,

• Patients with an HIV infection

• patients having given their written informed consent.

Related Conditions & MeSH terms

• Patients Affected by the HIV

Intervention

Biological:
• OVIHD
7 ml of blood will be taken during a follow-up consultation and kept in a biological collection. Clinical data will be collected in a database.

Locations

Country	Name	City	State
France	Hôpital Hôtel Dieu	Paris

Sponsors (1)

Lead Sponsor	Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	HIV infection	The HIV cohort will be constituted in collecting cardiovascular, neurological clinical data and medical past history (in case of women patient)	10 years
Secondary	Comorbidity and complication in HIV infected patients	The HIV cohort will be constituted in collecting cardiovascular, neurological clinical data and medical past history (in case of women patient)	10 years
Secondary	efficiency of the current antiretroviral therapeutic diets	The HIV cohort will be constituted in collecting cardiovascular, neurological clinical data and medical past history (in case of women patient)	10 years
Secondary	Blood sample collection	To put in relation the clinical-biological relevant biological or genetic data of the follow-up a blood sample will be constituted. 7 ml will be taken to each patient and kept in a collection	10 years